Spectrum Pharmaceuticals announces that the FDA's Oncology Drug Advisory Committee (ODAC) will review their very promising investigational drug Satraplatin for the Treatment of Hormone Refractory Prostate Cancer. The hearing will be held on July 24, 2007. This is very exciting, especially in light of the FDA’s surprising failure to approve Provenge. A quick review of [...]
Either my little guy knows he's the financially unfortunate offspring of a non-profit operations director, and a social worker, or we're raising the next Earl Graves (a.k.a. Publisher and Board Chairman of Black Enterprise magazine).... A few days ago my little guy walked over to his mother with one of his old Thomas the Tank [...]
In today’s Wall Street Journal there is a fantastic opinion piece written by Dr. Mark Thornton, Black Wednesday at the FDA. Dr. Thornton points out that not only did the FDA not approve Provenge last Wednesday, but also it failed to approve Junovan, a immunological drug designed to treat young children with a rare bone [...]
Today is Mother's Day. Today is a day we remember and honor our own mother and our spouses. These are the very same women who have been our loving caretakers, a job that gets little gratitude and no pay. Often, we are guilty of not paying attention to them and of responding to their comments [...]
The Wall Street Journal's health blog has exploded with comments about the recent article about the FDA and Provenge. Their piece along with the comments are a must read. You can see the blog at: The Wall Street Journal Health Blog Please don't forget to www.malecare.com and sign our letter to the FDA. Our letter [...]